Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic Kidney Disease
Interventions
DRUG

Pitavastatin

DRUG

Atorvastatin

Trial Locations (2)

602715

Dong-A University, Busan

602-715

Won Suk An, Busan

All Listed Sponsors
lead

Dong-A University

OTHER

NCT02863185 - Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter